UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

~~July~~April 2117, ~~2025~~2026

Date of Report (Date of earliest event reported)

Burzynski Research Institute, Inc.

(Exact name of registrant as specified in its charter)

Delaware		000-23425		76-0136810
(State or other jurisdiction of incorporation)		(Commission File Number)		(I.R.S. Employer Identification Number)

9432 Katy Freeway, Suite 200, Houston, TX 77055

(Address of principal executive offices)

(713) 335-5697

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

	¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

	¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

	¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

	¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
None		BZYR		None

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b–2 of the Securities Exchange Act of 1934 (§240.12b–2 of this chapter).

Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 45.0102 ~~Changes~~Departure inof ~~Registrant’s~~Directors ~~Certifying~~or ~~Accountant~~Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On ~~July~~April 2116, ~~2025~~2026, ~~Burzynski Research~~Patryk ~~Institute, Inc~~P. ~~(the~~Goscianski ~~“Company”),~~resigned as ~~received~~the ~~notice~~Chief ~~from~~Financial ~~Pannell~~Officer ~~Kerr Forster of Texas, P.C.~~ (~~“PKF”),~~principal ~~the~~financial ~~Company’s~~officer ~~independent~~and ~~registered~~principal ~~public~~ accounting ~~firm,~~officer) ~~notifying~~ (the ~~Company~~“CFO”) ~~that PKF had been recently acquired by another accounting firm~~ and ~~would~~Secretary ~~not be able to act as the Company’s registered public accounting~~of ~~firm~~Burzynski inResearch ~~the future~~Institute, Inc. As(the ~~such~~“Company”), ~~the~~ effective ~~date~~on ~~of such resignation was July~~April 2117, ~~2025~~2026.

~~The~~Mr. Goscianski’s ~~Company~~resignation ~~intends~~was ~~to engage~~not athe ~~new~~result ~~independent~~of ~~registered~~any ~~public~~disagreement ~~accounting~~with ~~firm~~the asCompany ~~soon~~on asany ~~possible~~matter ~~and~~relating ~~will~~to ~~file~~the aCompany’s ~~Form 8-K/A~~operations, ~~when~~policies, ~~the~~or ~~new~~practices. ~~independent~~A ~~registered~~copy ~~public~~of ~~accounting~~Mr. Goscianski’s ~~firm~~resignation ~~has~~letter ~~been~~is ~~appointed~~filed as Exhibit 17.1 to this Current Report on Form 8-K.

~~During~~Effective ~~the~~on ~~Company’s two most recent fiscal years (ended February~~April 2817, ~~2025 and February 29~~2026, ~~2024) and~~ the ~~subsequent~~Board ~~interim period through May 31, 2025, there were no “disagreements” (within the meaning~~ of ~~Item 304(a)(1)(iv) of Regulation S-K and the related instructions~~ ~~under~~Directors ~~the~~appointed ~~Securities~~Stanislaw ~~Exchange~~R. ~~Act~~Burzynski, ~~of 1934~~M.D., Ph.D. as ~~amended (~~the ~~“Exchange Act”)) between the~~ Company’s ~~and~~Chief ~~PKF~~Financial onOfficer ~~any~~(principal ~~matter~~financial ofofficer ~~accounting~~and ~~principles~~principal oraccounting ~~practices,~~officer) ~~financial~~and ~~statement~~Secretary. ~~disclosure~~Dr. Burzynski orcurrently ~~auditing~~serves ~~scope~~as orthe ~~procedure,~~Company’s ~~which disagreements~~President, ifChairman ~~not~~of ~~resolved to~~ the ~~satisfaction~~Board of ~~PKF,~~Directors ~~would~~and ~~have~~principal ~~caused~~executive ~~PKF~~officer, toand ~~make~~as ~~reference~~a toresult ~~the subject matter~~ of ~~the disagreements in its reports on the financial statements of the Company for such years. Also during~~ this ~~same period~~appointment, ~~there~~Dr. Burzynski ~~were~~will noserve ~~“reportable~~as ~~events”~~both ~~(within~~ the ~~meaning of Item~~Company’s ~~304(a)(1)(v) of~~principal ~~Regulation~~executive ~~S-K~~officer and ~~the~~principal ~~related~~financial ~~instructions under the Exchange Act)~~officer.

~~The Company has provided PKF with a copy of the foregoing disclosures under Item 4~~Dr.~~01 on Form~~ ~~8-K~~Burzynski ~~prior~~will tonot ~~filing~~receive itany ~~with the U.S. Securities and Exchange Commission~~additional ~~(“SEC”)~~compensation ~~and~~in ~~has~~connection ~~requested that PKF furnish the Company~~ with ~~a letter addressed to the SEC stating whether it agrees with the statements made by the Company under Item 4.01 of~~ this ~~Form 8-K~~appointment. ~~A copy of PKF’s letter, dated July 24, 2025, is attached as Exhibit 16.1 to this report on Form 8-K.~~

Dr. Burzynski, 83, is the Company’s controlling stockholder and is a party to the New License Agreement, the Amended and Restated Research Funding Agreement and the Royalty Agreement with the Company as described in the Company’s Annual Report on Form 10-K for the year-ended February 28, 2025, which descriptions are incorporated herein by reference. Dr. Burzynski is the father of Gregory S. Burzynski and step-father of Monika Szopa-Paszkowiski, the other two members of the Company’s Board of Directors. Dr. Burzynski’s biographical history is set forth in the Company’s Annual Report on Form 10-K for the year-ended February 28, 2025. Other than these three agreements, there are no related party transactions required to be disclosed pursuant to Item 404(a) of Regulation S-K in connection with Dr. Burzynski’s appointment as CFO and Secretary.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.		Description
Exhibit 17.1		Resignation Letter of Patryk P. Goscianski, dated April 16, 2026.
16.1		Letter dated July 24, 2025 from PKF to the Securities and Exchange Commission confirming the disclosures contained in Item 4.01 of this report on Form 8-K..
104		Cover Page Interactive File (the cover page tags are embedded within the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: July 24, 2025	BURZYNSKI RESEARCH INSTITUTE, INC.
Date: April 23, 2026	BURZYNSKI RESEARCH INSTITUTE, INC.
	By:	/s/ Stanislaw R. Burzynski
		Stanislaw R. Burzynski
		President and Chairman of the Board of Director
		President, Chief Financial Officer, Secretary and Chairman of the Board of Directors

Filing Compare · BURZYNSKI RESEARCH INSTITUTE INC